| Q39996005 | A novel form of NF-kappaB is induced by Leishmania infection: involvement in macrophage gene expression. |
| Q34156179 | A novel protein overexpressed in hepatoma accelerates export of NF-kappa B from the nucleus and inhibits p53-dependent apoptosis |
| Q35488924 | Activation of NF-κB by human papillomavirus 16 E1 limits E1-dependent viral replication through degradation of E1. |
| Q58779438 | Constitutive activation and overexpression of NF-κB/c-Rel in conjunction with p50 contribute to aggressive tongue tumorigenesis |
| Q57996111 | Deficiencies in myeloid antigen-presenting cells in women with cervical squamous intraepithelial lesions |
| Q41837402 | Deregulation of the miRNAs expression in cervical cancer: human papillomavirus implications |
| Q104495217 | Evaluation of HPV16 E7 expression in head and neck carcinoma cell lines and clinical specimens |
| Q52764289 | Folic acid conjugated polymeric micelles loaded with a curcumin difluorinated analog for targeting cervical and ovarian cancers. |
| Q40260839 | Gene expression profiles reveal an upregulation of E2F and downregulation of interferon targets by HPV18 but no changes between keratinocytes with integrated or episomal viral genomes |
| Q42468679 | HPV-18 confers resistance to TNF-alpha in organotypic cultures of human keratinocytes. |
| Q60916954 | HPV-Mediated Resistance to TNF and TRAIL Is Characterized by Global Alterations in Apoptosis Regulatory Factors, Dysregulation of Death Receptors, and Induction of ROS/RNS |
| Q42218400 | HPV16 E2-mediated potentiation of NF-κB activation induced by TNF-α involves parallel activation of STAT3 with a reduction in E2-induced apoptosis |
| Q40475356 | High levels of p105 (NFKB1) and p100 (NFKB2) proteins in HPV16-transformed keratinocytes: role of E6 and E7 oncoproteins. |
| Q28084802 | High-risk human papillomavirus targets crossroads in immune signaling |
| Q34743768 | Human papillomavirus (HPV) upregulates the cellular deubiquitinase UCHL1 to suppress the keratinocyte's innate immune response |
| Q36305948 | Human papillomavirus and disease mechanisms: relevance to oral and cervical cancers |
| Q37315925 | Human papillomavirus and molecular considerations for cancer risk |
| Q33851664 | Human papillomavirus deregulates the response of a cellular network comprising of chemotactic and proinflammatory genes |
| Q36216805 | Human papillomavirus genotypes in penile cancers from Japanese patients and HPV-induced NF-κB activation |
| Q39445934 | Human papillomavirus infection induces NF-κB activation in cervical cancer: A comparison with penile cancer |
| Q35787928 | Human papillomavirus type 16 E6 and E 7 proteins alter NF-kB in cultured cervical epithelial cells and inhibition of NF-kB promotes cell growth and immortalization |
| Q40430288 | Human papillomavirus type 16 E6 and E7 oncoproteins upregulate c-IAP2 gene expression and confer resistance to apoptosis |
| Q36827288 | Human papillomaviruses modulate microRNA 145 expression to directly control genome amplification |
| Q42030463 | Identification of key amino acid residues that determine the ability of high risk HPV16-E7 to dysregulate major histocompatibility complex class I expression. |
| Q40543156 | Inhibition of nuclear factor kappaB activity by viral interferon regulatory factor 3 of Kaposi's sarcoma-associated herpesvirus. |
| Q37748135 | Macrophages kill human papillomavirus type 16 E6-expressing tumor cells by tumor necrosis factor alpha- and nitric oxide-dependent mechanisms |
| Q39003287 | Manipulation of the innate immune response by human papillomaviruses |
| Q40361594 | Mechanism for removal of tumor necrosis factor receptor 1 from the cell surface by the adenovirus RIDalpha/beta complex. |
| Q27002467 | Mechanisms of virus immune evasion lead to development from chronic inflammation to cancer formation associated with human papillomavirus infection |
| Q39083904 | Merkel cell polyomavirus small T antigen targets the NEMO adaptor protein to disrupt inflammatory signaling |
| Q34309882 | Merkel cell polyomavirus: molecular insights into the most recently discovered human tumour virus |
| Q28709497 | Modulation of NF-κB signalling by microbial pathogens |
| Q54651730 | Molecular cloning of IKKβ from the mandarin fish Siniperca chuatsi and its up-regulation in cells by ISKNV infection. |
| Q38343954 | NF-κ B-dependent upregulation of ICAM-1 by HPV16-E6/E7 facilitates NK cell/target cell interaction. |
| Q24292906 | NF-κB signalling is attenuated by the E7 protein from cutaneous human papillomaviruses |
| Q34563758 | NF-κB-induced KIAA1199 promotes survival through EGFR signalling |
| Q42411008 | NFX1 plays a role in human papillomavirus type 16 E6 activation of NFkappaB activity |
| Q27487296 | Negative regulation of cytoplasmic RNA-mediated antiviral signaling |
| Q37316158 | Oncogenic activities of human papillomaviruses |
| Q55049874 | Oxidative stress in female cancers. |
| Q90399211 | Phenyllactic acid promotes cell migration and invasion in cervical cancer via IKK/NF-κB-mediated MMP-9 activation |
| Q36217010 | Relationship among human papillomavirus infection, p16(INK4a), p53 and NF-κB activation in penile cancer from northern Thailand |
| Q37002546 | Role of WDHD1 in Human Papillomavirus-Mediated Oncogenesis Identified by Transcriptional Profiling of E7-Expressing Cells |
| Q44269684 | Role of human papillomavirus infection in carcinogenesis of oral squamous cell carcinoma with evidences of prognostic association |
| Q37192229 | Rotavirus antagonizes cellular antiviral responses by inhibiting the nuclear accumulation of STAT1, STAT2, and NF-kappaB. |
| Q98881813 | Structural and functional impacts of E5 genetic variants of human papillomavirus type 31 |
| Q64084618 | The Double-Edged Sword-How Human Papillomaviruses Interact With Immunity in Head and Neck Cancer |
| Q57218500 | The E5 protein of human papillomavirus type 16 perturbs MHC class II antigen maturation in human foreskin keratinocytes treated with interferon-gamma |
| Q40444191 | The Interaction Between Human Papillomaviruses and the Stromal Microenvironment |
| Q90270888 | The Interplay between Antiviral Signalling and Carcinogenesis in Human Papillomavirus Infections |
| Q38428005 | The biomarkers of human papillomavirus infection in tonsillar squamous cell carcinoma-molecular basis and predicting favorable outcome |
| Q40645798 | The early response gene IEX-1 attenuates NF-kappaB activation in 293 cells, a possible counter-regulatory process leading to enhanced cell death |
| Q41055909 | The human papillomavirus (HPV) E7 protein antagonises an Imiquimod-induced inflammatory pathway in primary human keratinocytes |
| Q39000409 | The human papillomavirus E7 oncoprotein as a regulator of transcription |
| Q35245080 | The interferon-related developmental regulator 1 is used by human papillomavirus to suppress NFκB activation. |
| Q37198662 | The papillomavirus E7 proteins |
| Q54707844 | Tissue transglutaminase 2 as a biomarker of cervical intraepithelial neoplasia (CIN) and its relationship to p16INK4A and nuclear factor kappaB expression. |
| Q47775964 | Typing of human papillomavirus in Zimbabwean patients with invasive cancer of the uterine cervix |
| Q44092048 | Upregulation of nuclear factor-kappaB (NF-kappaB) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus or disease outcome in cervical cancer |
| Q28507062 | WAVE2 deficiency reveals distinct roles in embryogenesis and Rac-mediated actin-based motility |
| Q39127526 | Zinc finger A20 and NF-κB correlate with high-risk human papillomavirus of squamous cell carcinoma patients |